These results are shown in Figure 2A (patients with high (red) and low (blue) PHLDA1 overexpression in the colon, brain, lymphoma, kidney, pancreatic, and skin cancers and PHLDA1 downregulation in the breast, esophageal, and liver (Table S1). This evidence concerns the gene PHLDA1 and lymphoma.